Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-31 Heerma Peter CHIEF COMMERCIAL OFFICER Grant or award +26,120 139,133
2026-01-31 Heerma Peter CHIEF COMMERCIAL OFFICER Grant or award · Employee stock option (right to buy) +69,640 69,640
2026-01-31 Dube Eric M CHIEF EXECUTIVE OFFICER Grant or award 10b5-1 +113,800 532,973
2026-01-31 Dube Eric M CHIEF EXECUTIVE OFFICER Grant or award · Employee stock option (right to buy) 10b5-1 +303,600 303,600
2026-01-31 ROTE WILLIAM E. Chief Research Officer Grant or award 10b5-1 +20,090 121,533
2026-01-31 ROTE WILLIAM E. Chief Research Officer Grant or award · Employee stock option (right to buy) 10b5-1 +53,570 53,570
2026-01-31 REED ELIZABETH E Chief Legal Officer and GC Grant or award +25,110 115,380
2026-01-31 REED ELIZABETH E Chief Legal Officer and GC Grant or award · Employee stock option (right to buy) +66,960 66,960
2026-01-27 Dube Eric M CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +51,865 $15.46 $802K 471,038
2026-01-27 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −51,865 $30.10 $1.6M 419,173
2026-01-27 Dube Eric M CHIEF EXECUTIVE OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −51,865 120,000
2026-01-23 Dube Eric M CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +8,135 $15.46 $126K 427,308
2026-01-23 Dube Eric M CHIEF EXECUTIVE OFFICER Sale 10b5-1 −8,135 $30.01 $244K 419,173
2026-01-23 Dube Eric M CHIEF EXECUTIVE OFFICER Option exercise · Employee stock option (right to buy) 10b5-1 −8,135 171,865
2026-01-20 REED ELIZABETH E Chief Legal Officer and GC Option exercise 10b5-1 +10,000 $19.08 $191K 100,270
2026-01-20 REED ELIZABETH E Chief Legal Officer and GC Sale 10b5-1 −10,000 $27.34 $273K 90,270
2026-01-20 REED ELIZABETH E Chief Legal Officer and GC Option exercise · Employee stock option (right to buy) 10b5-1 −10,000 30,000
2026-01-06 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −445 $37.75 $17K 86,311
2026-01-05 Inrig Jula CHIEF MEDICAL OFFICER Sale 10b5-1 −2,031 $40.18 $82K 86,756
2025-12-24 Inrig Jula CHIEF MEDICAL OFFICER Option exercise 10b5-1 +15,000 $8.93 $134K 103,787

Page 14 of 51 · 1,020 trades